QIA/ NL0015001WM6 /
28/05/2024 08:02:23 | Chg. -0.2300 | Volume | Bid08:49:36 | Ask08:49:36 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
40.0500EUR | -0.57% | 0 Turnover: 0.0000 |
-Bid Size: - | -Ask Size: - | 9.18 bill.EUR | - | - |
GlobeNewswire
14/05
QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire
13/05
QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire
07/05
QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire
02/05
QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire
29/04
QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance
GlobeNewswire
24/04
QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and comba...
GlobeNewswire
10/04
Questex’s IHIF EMEA 2024: The Meeting Place of Hospitality Innovators and Game-Changers
GlobeNewswire
03/04
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Ann...
GlobeNewswire
25/03
QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration a...
GlobeNewswire
18/03
QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosi...
GlobeNewswire
27/02
QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discovery
GlobeNewswire
27/02
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
15/02
QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Plati...
GlobeNewswire
06/02
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved op...
GlobeNewswire
25/01
QIAGEN announces partnership with Penn State University to advance microbiome sciences
GlobeNewswire
18/01
QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 mi...
GlobeNewswire
08/01
QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular Sy...